All Featured Insights

All ACIP committee members dismissed, dozens of states sue 23andMe, FDA to use AI in drug approvals

CBO releases coverage impacts of One Big Beautiful Bill, 5th Circuit to rehear No Surprises Act challenge, many Epic customers live on TEFCA.

RFK Jr. clears Senate panel, federal and state policy battle over transgender care comes to head in New York, Moody’s downgrades health insurer credit outlook

OMB memo causes significant confusion, Change cyberattack affected 190 million people, Cigna to limit out-of-pocket drug costs.

SCOTUS to hear challenge to ACA preventive care mandate, DEA proposes telehealth rule for controlled substances, FDA announces three regulations

CMS finalizes the 2025 OPPS rule, an appeals court rules reverses a No Surprises Act decision, and MACPAC calls for more Medicaid payment oversight.

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation.

The House Oversight Committee criticizes PBM pricing tactics, Humana’s CenterWell plans to open primary care centers at Walmarts, and a federal judge upholds the FTC’s noncompete rule, diverging from a previous district court ruling.

Novant cancels its plan to acquire two North Carolina hospitals from CHS amid an FTC challenge, Amazon expands its RxPass generic drug subscription service to Medicare, and the DOJ accuses two executives at telehealth startup Done of an Adderall distribution scheme.